{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:07:00Z","timestamp":1794884820505,"version":"4.9.1"},"reference-count":174,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003083","name":"European Association of Urology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eururo.2025.04.010","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:31:23Z","timestamp":1746725483000},"page":"76-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie\u2019s Disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Andrea","family":"Salonia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Capogrosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Boeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marij","family":"Dinkelman-Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Fuglesang","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Kalkanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ates","family":"Kadio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Martinez-Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Afonso Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio I.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ege Can","family":"Serefo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suks","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.04.010_b0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of Urology guidelines on sexual and reproductive health\u20142021 update: male sexual dysfunction","volume":"80","author":"Salonia","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2025.04.010_b0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-019-0087-y","article-title":"Paediatric and adult-onset male hypogonadism","volume":"5","author":"Salonia","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.eururo.2025.04.010_b0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.beem.2011.12.005","article-title":"Subclinical male hypogonadism","volume":"26","author":"Giannetta","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.04.010_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102323","article-title":"Pharmacotherapy of male hypogonadism","volume":"68","author":"Rastrelli","year":"2023","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.eururo.2025.04.010_b0030","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/andr.12850","article-title":"Critical evaluation of different available guidelines for late\u2010onset hypogonadism","volume":"8","author":"Giagulli","year":"2020","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.04.010_b0035","doi-asserted-by":"crossref","first-page":"E321","DOI":"10.1503\/cmaj.150262","article-title":"Predicting low testosterone in aging men: a systematic review","volume":"188","author":"Millar","year":"2016","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.eururo.2025.04.010_b0040","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/andr.12993","article-title":"Severely low testosterone in males with COVID\u201019: a case\u2010control study","volume":"9","author":"Salonia","year":"2021","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.04.010_b0045","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s40618-022-01801-x","article-title":"Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis","volume":"45","author":"Corona","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.04.010_b0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.sxmr.2018.10.006","article-title":"Testosterone and benign prostatic hyperplasia","volume":"7","author":"Rastrelli","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.04.010_b0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12020-018-1741-y","article-title":"Oral glucose load and mixed meal feeding lowers testosterone levels in healthy eugonadal men","volume":"63","author":"Gagliano-Juc\u00e1","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.eururo.2025.04.010_b0060","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/EJE-15-0262","article-title":"Therapy of endocrine disease: testosterone supplementation and body composition: results from a meta-analysis study","volume":"174","author":"Corona","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.04.010_b0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0070","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1530\/EJE-11-1051","article-title":"Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men","volume":"166","author":"Huhtaniemi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.04.010_b0075","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-8703(94)90679-3","article-title":"Hematocrit and the risk of cardiovascular disease\u2014the Framingham study: a 34-year follow-up","volume":"127","author":"Gagnon","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.eururo.2025.04.010_b0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5534\/wjmh.210021","article-title":"Consequences of anabolic-androgenic steroid abuse in males; sexual and reproductive perspective","volume":"40","author":"Corona","year":"2022","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2025.04.010_b0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1517\/14656566.2015.993607","article-title":"The pharmacotherapy of male hypogonadism besides androgens","volume":"16","author":"Corona","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eururo.2025.04.010_b0090","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.eururo.2017.03.032","article-title":"Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function scores","volume":"72","author":"Corona","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.sxmr.2018.11.005","article-title":"Testosterone replacement therapy for sexual symptoms","volume":"7","author":"Rastrelli","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.04.010_b0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/clinem\/dgad484","article-title":"Effect of testosterone replacement therapy on sexual function and hypogonadal symptoms in men with hypogonadism","volume":"109","author":"Pencina","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.04.010_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cen.13723","article-title":"Hypogonadism and male obesity: focus on unresolved questions","volume":"89","author":"Grossmann","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eururo.2025.04.010_b0110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EJE-12-0955","article-title":"Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis","volume":"168","author":"Corona","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.04.010_b0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5534\/wjmh.190061","article-title":"Treatment of functional hypogonadism besides pharmacological substitution","volume":"38","author":"Corona","year":"2020","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2025.04.010_b0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eururo.2025.04.010_b0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17512433.2018.1445969","article-title":"Pharmacological management of late-onset hypogonadism","volume":"11","author":"Rastrelli","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.eururo.2025.04.010_b0130","doi-asserted-by":"crossref","first-page":"R365","DOI":"10.1530\/ERC-18-0117","article-title":"The endocrinology of male breast cancer","volume":"25","author":"Fentiman","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.eururo.2025.04.010_b0135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s40618-022-01776-9","article-title":"Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial","volume":"45","author":"Rastrelli","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.04.010_b0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jsxm.2016.06.003","article-title":"Effects of 8-year treatment of long-acting testosterone undecanoate on metabolic parameters, urinary symptoms, bone mineral density, and sexual function in men with late-onset hypogonadism","volume":"13","author":"Permpongkosol","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bju.13578","article-title":"Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men","volume":"119","author":"Debruyne","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0150","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40618-016-0461-5","article-title":"Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry","volume":"39","author":"Rastrelli","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.04.010_b0155","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.eururo.2013.03.042","article-title":"The effect of androgen-replacement therapy on prostate growth: a systematic review and meta-analysis","volume":"64","author":"Cui","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0160","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bju.13417","article-title":"Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate\u2010specific antigen (PSA) level: a meta\u2010analysis","volume":"118","author":"Boyle","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urology.2018.07.064","article-title":"Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis","volume":"126","author":"Teeling","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0170","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jsxm.2018.06.012","article-title":"Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies","volume":"15","author":"Corona","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-11-0447","article-title":"Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study","volume":"165","author":"Corona","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.04.010_b0180","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","article-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double\u2010blinded placebo\u2010controlled Moscow study","volume":"73","author":"Kalinchenko","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eururo.2025.04.010_b0185","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.04.010_b0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thromres.2020.12.029","article-title":"Testosterone replacement therapy and the risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials","volume":"199","author":"Ayele","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0195","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jsxm.2018.04.641","article-title":"Testosterone and cardiovascular risk: meta-analysis of interventional studies","volume":"15","author":"Corona","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehi443","article-title":"Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial","volume":"27","author":"Malkin","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eururo.2025.04.010_b0205","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","article-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eururo.2025.04.010_b0210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13685538.2022.2063830","article-title":"The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men","volume":"25","author":"Zitzmann","year":"2022","journal-title":"Aging Male"},{"key":"10.1016\/j.eururo.2025.04.010_b0215","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/jim-2017-000411","article-title":"Testosterone treatment and cardiovascular and venous thromboembolism risk: what is \u2018new\u2019?","volume":"65","author":"Corona","year":"2017","journal-title":"J Investig Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0220","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-12-0525","article-title":"Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial","volume":"167","author":"Hoyos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.04.010_b0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eururo.2025.04.010_b0230","unstructured":"NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. 1993."},{"key":"10.1016\/j.eururo.2025.04.010_b0235","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2009.01457.x","article-title":"Erectile dysfunction (ED) is a shared sexual concern of couples i: couple conceptions of ED","volume":"6","author":"Fisher","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0240","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jsxm.2016.05.017","article-title":"Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires","volume":"13","author":"Hatzichristou","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0245","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0250","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1743-6109.2012.02823.x","article-title":"Standard operating procedures for taking a sexual history","volume":"10","author":"Althof","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1743-6109.2012.02734.x","article-title":"SOP: physical examination and laboratory testing for men with erectile dysfunction","volume":"10","author":"Ghanem","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0265","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41443-022-00565-5","article-title":"Can we rely on total testosterone measurement to exclude hypogonadism in erectile dysfunction?","volume":"35","author":"Morgado","year":"2023","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0270","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1743-6109.2012.02735.x","article-title":"Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA)","volume":"10","author":"Maggi","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0275","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/jsm.12715","article-title":"Changes in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) survey","volume":"12","author":"Fang","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0280","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000499249","article-title":"Is the history of erectile dysfunction a reliable risk factor for new onset acute myocardial infarction? A systematic review and meta-analysis","volume":"14","author":"Adam","year":"2020","journal-title":"Curr Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/jsxmed\/qdad163","article-title":"Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health","volume":"21","author":"Kloner","year":"2024","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0290","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.eururo.2025.04.010_b0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41443-020-0249-1","article-title":"Men\u2019s beliefs about treatment for erectile dysfunction\u2014what influences treatment use? A systematic review","volume":"33","author":"Williams","year":"2021","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0300","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10508-012-0062-0","article-title":"Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis","volume":"42","author":"Fr\u00fchauf","year":"2013","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.eururo.2025.04.010_b0305","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinternmed.2011.440","article-title":"The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction","volume":"171","author":"Gupta","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0310","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41585-019-0210-6","article-title":"Physical activity as an adjunct treatment for erectile dysfunction","volume":"16","author":"Allen","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0315","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2013.01.012","article-title":"Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis","volume":"63","author":"Yuan","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0320","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.eururo.2015.03.031","article-title":"Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis","volume":"68","author":"Chen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0325","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00345-020-03233-9","article-title":"Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis","volume":"39","author":"Madeira","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0330","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.eururo.2004.12.005","article-title":"Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders","volume":"47","author":"Hatzichristou","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.eururo.2006.02.060","article-title":"Treatment strategy for \u201cnon-responders\u201d to tadalafil and vardenafil: a real-life study","volume":"50","author":"Hatzimouratidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eururo.2013.08.048","article-title":"A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment\u2014a systematic review","volume":"65","author":"Isidori","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0345","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1464-410X.2007.06916.x","article-title":"Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men na\u00efve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open\u2010label, crossover study","volume":"100","author":"Eardley","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0350","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36337","article-title":"Assessment of combination therapies vs monotherapy for erectile dysfunction","volume":"4","author":"Mykoniatis","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2025.04.010_b0355","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.urology.2006.02.027","article-title":"An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients","volume":"68","author":"Padma-Nathan","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0360","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41443-018-0087-6","article-title":"The intra-meatal application of alprostadil cream (Vitaros\u00ae) improves drug efficacy and patient\u2019s satisfaction: results from a randomized, two-administration route, cross-over clinical trial","volume":"31","author":"Cai","year":"2019","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0365","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0022-5347(05)64170-5","article-title":"Prevalence of prostatitis-like symptoms in a community based cohort of older men","volume":"168","author":"Roberts","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(99)00442-2","article-title":"Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional ACTIS: a comparative, randomized, crossover, multicenter study","volume":"55","author":"Shabsigh","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0375","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2009.01627.x","article-title":"Pharmacotherapy for erectile dysfunction","volume":"7","author":"Eardley","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0380","article-title":"A psychosocial approach to erectile dysfunction: position statements from the European Society of Sexual Medicine (ESSM)","volume":"9","author":"Dewitte","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0385","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ijir.2010.4","article-title":"Vacuum therapy in erectile dysfunction\u2014science and clinical evidence","volume":"22","author":"Yuan","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0022-5347(17)36059-7","article-title":"Long-term results with vacuum constriction device","volume":"149","author":"Cookson","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0395","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jsxm.2016.09.008","article-title":"External mechanical devices and vascular surgery for erectile dysfunction","volume":"13","author":"Trost","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0400","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jsxm.2019.07.016","article-title":"Low-intensity shock wave therapy in sexual medicine\u2014clinical recommendations from the European Society of Sexual Medicine (ESSM)","volume":"16","author":"Capogrosso","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0405","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eururo.2016.05.050","article-title":"Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis","volume":"71","author":"Lu","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0410","article-title":"Evaluation of long-term clinical outcomes and patient satisfaction rate following low intensity shock wave therapy in men with erectile dysfunction: a minimum 5-year follow-up on a prospective open-label single-arm clinical study","volume":"9","author":"Chung","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0415","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.juro.2015.12.049","article-title":"Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: a double-blind, sham controlled study","volume":"195","author":"Kitrey","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0420","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jsxm.2021.03.008","article-title":"Platelet-rich plasma (PRP) improves erectile function: a double-blind, randomized, placebo-controlled clinical trial","volume":"18","author":"Poulios","year":"2021","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0425","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.urology.2023.01.028","article-title":"Is platelet rich plasma safe and effective in treatment of erectile dysfunction? Randomized controlled study","volume":"175","author":"Shaher","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0430","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/JU.0000000000003685","article-title":"Platelet-rich plasma for the treatment of erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled clinical trial","volume":"210","author":"Masterson","year":"2023","journal-title":"Reply. J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0435","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41443-023-00798-y","article-title":"Platelet-rich plasma intracavernosal injections for the treatment of primary organic erectile dysfunction: a systematic review and meta-analysis of contemporary controlled studies","volume":"36","author":"Panunzio","year":"2024","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0440","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/sxmrev\/qead040","article-title":"Stem cell therapy for erectile dysfunction: a systematic review","volume":"12","author":"Furtado","year":"2023","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.04.010_b0445","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/andr.13104","article-title":"Safety and efficacy of botulinum neurotoxin in the treatment of erectile dysfunction refractory to phosphodiesterase inhibitors: results of a randomized controlled trial","volume":"10","author":"Abdelrahman","year":"2022","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.04.010_b0450","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/andr.13010","article-title":"Intra\u2010cavernous injection of BOTOX \u00ae (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: randomized controlled trial","volume":"9","author":"El\u2010Shaer","year":"2021","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.04.010_b0455","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1743-6109.2012.02997.x","article-title":"Standard operating procedures for vascular surgery in erectile dysfunction: revascularization and venous procedures","volume":"10","author":"Sohn","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0460","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00345-012-0859-4","article-title":"Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures","volume":"31","author":"Chung","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0465","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1743-6109.2009.01626.x","article-title":"Implants, mechanical devices, and vascular surgery for erectile dysfunction","volume":"7","author":"Hellstrom","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0470","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.sxmr.2018.03.007","article-title":"Comparison of infrapubic vs penoscrotal approaches for 3-piece inflatable penile prosthesis placement: do we have a winner?","volume":"6","author":"Palmisano","year":"2018","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.04.010_b0475","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1743-6109.2012.02729.x","article-title":"A survey of patients with inflatable penile prostheses: assessment of timing and frequency of intercourse and analysis of implant durability","volume":"9","author":"Henry","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0480","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.sxmr.2019.07.005","article-title":"Infectious adverse events following the placement of a penile prosthesis: a systematic review","volume":"8","author":"Mahon","year":"2020","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.04.010_b0485","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1743-6109.2011.02524.x","article-title":"An outcomes analysis of over 200 revision surgeries for penile prosthesis implantation: a multicenter study","volume":"9","author":"Henry","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0490","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.sxmr.2018.04.002","article-title":"Penile prosthesis complications: planning, prevention, and decision making","volume":"7","author":"Scherzer","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.04.010_b0495","unstructured":"World Health Organization. International Classification of Diseases 11th revision for mortality and morbidity statistics (ICD-11-MMS). The global standard for diagnostic health information; 2018."},{"key":"10.1016\/j.eururo.2025.04.010_b0500","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. ed. 5. Arlington, VA: American Psychiatric Association; 2013. https:\/\/psychiatryonline.org\/dsm.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.eururo.2025.04.010_b0505","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jsm.12524","article-title":"An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the definition of premature ejaculation","volume":"11","author":"Serefoglu","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0510","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/ijcp.12843","article-title":"Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review","volume":"70","author":"Russo","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2025.04.010_b0515","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jsm.12504","article-title":"An update of the International Society of Sexual Medicine\u2019s guidelines for the diagnosis and treatment of premature ejaculation (PE)","volume":"11","author":"Althof","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0520","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/bju.13002","article-title":"A prospective study of erectile function after transrectal ultrasonography\u2010guided prostate biopsy","volume":"116","author":"Murray","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0525","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","article-title":"Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis","volume":"16","author":"Waldinger","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0530","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1743-6109.2010.01975.x","article-title":"International Society for Sexual Medicine\u2019s guidelines for the diagnosis and treatment of premature ejaculation","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0535","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eururo.2007.01.028","article-title":"Development and validation of a premature ejaculation diagnostic tool","volume":"52","author":"Symonds","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0540","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1743-6109.2006.00213.x","article-title":"Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE)","volume":"4","author":"Arafa","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0545","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/jsm.12925","article-title":"The combination of dapoxetine and behavioral treatment provides better results than dapoxetine alone in the management of patients with lifelong premature ejaculation","volume":"12","author":"Cormio","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0550","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.04.010_b0555","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5144\/0256-4947.2018.366","article-title":"Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized controlled trials with trial sequential analysis","volume":"38","author":"Li","year":"2018","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0560","article-title":"Safety and effectiveness of dapoxetine on demand in Chinese men with premature ejaculation: results of a multicenter, prospective, open-label phase IV study","volume":"9","author":"Peng","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0565","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.esxm.2017.02.003","article-title":"Discontinuation of dapoxetine treatment in patients with premature ejaculation: a 2-year prospective observational study","volume":"5","author":"Park","year":"2017","journal-title":"Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0570","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/jsm.12236","article-title":"Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study","volume":"10","author":"McMahon","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0575","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1176\/ajp.151.9.1377","article-title":"Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study","volume":"151","author":"Waldinger","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eururo.2025.04.010_b0580","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12894-018-0431-7","article-title":"Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0585","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5534\/wjmh.210155","article-title":"Selective serotonin re-uptake inhibitors for premature ejaculation in adult men: a Cochrane systematic review","volume":"40","author":"Sathianathen","year":"2022","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2025.04.010_b0590","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41443-017-0011-5","article-title":"Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose, parallel-grouped clinical study","volume":"30","author":"Kim","year":"2018","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/uj.5000275","article-title":"FortacinTM spray for the treatment of premature ejaculation","volume":"84","author":"Porst","year":"2017","journal-title":"Urol J"},{"issue":"11 Pt C","key":"10.1016\/j.eururo.2025.04.010_b0600","first-page":"E943","article-title":"The role of local anaesthetics in premature ejaculation","volume":"110","author":"Wyllie","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0605","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5489\/cuaj.12002","article-title":"Evolving therapeutic strategies for premature ejaculation: The search for on-demand treatment \u2013 topical versus systemic","volume":"6","author":"Morales","year":"2012","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2025.04.010_b0610","first-page":"1029","article-title":"Influence of tramadol on neurotransmitter systems of the rat brain","volume":"46","author":"Frink","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.eururo.2025.04.010_b0615","doi-asserted-by":"crossref","DOI":"10.1177\/15579883211057713","article-title":"The influence of tramadol on intravaginal ejaculatory latency time and sexual satisfaction score in treating patients with premature ejaculation: a network meta-analysis","volume":"15","author":"Lu","year":"2021","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.eururo.2025.04.010_b0620","unstructured":"Food and Drug Administration. Warning letter to William Weldon, CEO & Chairman of Johnson & Johnson, regarding Ultram-ER web advertisement; 2009."},{"key":"10.1016\/j.eururo.2025.04.010_b0625","doi-asserted-by":"crossref","DOI":"10.1177\/1557988320916406","article-title":"Phosphodiesterase-5 inhibitors for premature ejaculation: systematic review and meta-analysis of placebo-controlled trials","volume":"14","author":"Zhang","year":"2020","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.eururo.2025.04.010_b0630","first-page":"280","article-title":"Effectiveness of \u201con demand\u201d silodosin in the treatment of premature ejaculation in patients dissatisfied with dapoxetine: a randomized control study","volume":"69","author":"Bhat","year":"2016","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0635","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.urology.2016.04.036","article-title":"On-demand modafinil improves ejaculation time and patient-reported outcomes in men with lifelong premature ejaculation","volume":"94","author":"Tuken","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0640","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5534\/wjmh.210007","article-title":"Efficacy and safety of penile girth enhancement using hyaluronic acid filler and the clinical impact on ejaculation: a multi-center, patient\/evaluator-blinded, randomized active-controlled trial","volume":"40","author":"Ahn","year":"2022","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2025.04.010_b0645","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jsxm.2018.09.006","article-title":"Pharmacokinetics, safety, and tolerability of single oral doses of a novel oxytocin receptor antagonist\u2014cligosiban\u2014in development for premature ejaculation: three randomized clinical trials in healthy subjects","volume":"15","author":"Osterloh","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0650","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jsxm.2019.12.014","article-title":"A double blind, placebo controlled, randomized trial to evaluate the efficacy and tolerability of on-demand oral pregabalin (150 mg and 75 mg) in treatment of premature ejaculation","volume":"17","author":"El Najjar","year":"2020","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0655","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jsxm.2019.01.319","article-title":"Anatomic basis and clinical effect of selective dorsal neurectomy for patients with lifelong premature ejaculation: a randomized controlled trial","volume":"16","author":"Liu","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jsxmed\/qdac012","article-title":"A novel on-demand therapy for lifelong premature ejaculation using a miniature transperineal electrical stimulator\u2014the vPatch: an as-treated analysis","volume":"20","author":"Shechter","year":"2023","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0665","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie\u2019s disease: validation of the Peyronie\u2019s disease questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0670","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jsxm.2016.04.062","article-title":"Evidence-based management guidelines on Peyronie\u2019s disease","volume":"13","author":"Chung","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0675","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie\u2019s disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0680","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1038\/sj.ijir.3901083","article-title":"Establishing a standardized evaluation of the man with Peyronie\u2019s disease","volume":"15","author":"Levine","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0685","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.ju.0000053800.62741.fe","article-title":"Peyronie\u2019s disease: a review","volume":"169","author":"Gholami","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0690","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.urology.2017.05.029","article-title":"Factors associated with erectile dysfunction and the Peyronie\u2019s disease questionnaire in patients with Peyronie\u2019s disease","volume":"107","author":"Serefoglu","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0695","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00345-019-02928-y","article-title":"Diagnostic utility of penile ultrasound in Peyronie\u2019s disease","volume":"38","author":"McCauley","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0700","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.ijir.3900569","article-title":"Color Doppler ultrasound assessment of penile vascular system in men with Peyronie\u2019s disease","volume":"12","author":"Kadio\u011flu","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0705","first-page":"E10","article-title":"Retraction statement: a double\u2010blind placebo\u2010controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie\u2019s disease","volume":"115","author":"Safarinejad","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0710","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jsxm.2020.06.022","article-title":"Phosphodiesterase type 5 inhibitors and selective estrogen receptor modulators can prevent but not reverse myofibroblast transformation in Peyronie\u2019s disease","volume":"17","author":"Ilg","year":"2020","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0715","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1743-6109.2011.02217.x","article-title":"The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes","volume":"8","author":"Chung","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0720","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11845-013-1036-5","article-title":"Effects of sildenafil treatment on patients with Peyronie\u2019s disease and erectile dysfunction","volume":"183","author":"Ozturk","year":"2014","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.eururo.2025.04.010_b0725","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41443-022-00651-8","article-title":"Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie\u2019s disease: a retrospective comparative analysis","volume":"36","author":"Spirito","year":"2024","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0730","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jsxm.2018.12.011","article-title":"Comparative effectiveness of intralesional therapy for Peyronie\u2019s disease in controlled clinical studies: a systematic review and network meta-analysis","volume":"16","author":"Russo","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0735","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.purol.2022.05.004","article-title":"Tolerance and efficacy of platelet-rich plasma injections in Peyronie\u2019s disease: pilot study","volume":"32","author":"Schirmann","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0740","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00345-019-02850-3","article-title":"Characteristics predictive of response to collagenase Clostridium histolyticum for Peyronie\u2019s disease: a review of the literature","volume":"38","author":"Masterson","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0745","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bju.13932","article-title":"Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie\u2019s disease using a new modified shortened protocol","volume":"120","author":"Abdel Raheem","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0750","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bju.13120","article-title":"Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie\u2019s disease (PD)","volume":"116","author":"Carson","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0755","first-page":"165","article-title":"Betamethasone versus placebo in Peyronie\u2019s disease","volume":"70","author":"Cipollone","year":"1998","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.eururo.2025.04.010_b0760","first-page":"2105","article-title":"Minimally invasive therapy using intralesional onabotulinumtoxinA in Peyronie\u2019s disease","volume":"12","author":"Mu\u00f1oz-Rangel","year":"2015","journal-title":"Urol J"},{"key":"10.1016\/j.eururo.2025.04.010_b0765","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euf.2022.08.017","article-title":"A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie\u2019s disease: clinical trial update","volume":"9","author":"Chu","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.04.010_b0770","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1743-6109.2008.01011.x","article-title":"Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to Peyronie\u2019s disease?","volume":"5","author":"Gelbard","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0775","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/bju.14602","article-title":"Penile traction therapy with the new device \u2018Penimaster PRO\u2019 is effective and safe in the stable phase of Peyronie\u2019s disease: a controlled multicentre study","volume":"123","author":"Moncada","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0780","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1871528112666131205112432","article-title":"Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie\u2019s disease (chronic inflammation of the tunica albuginea). Results of a controlled study","volume":"12","author":"Paulis","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.eururo.2025.04.010_b0785","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-410X.2010.09365.x","article-title":"The role of vacuum pump therapy to mechanically straighten the penis in Peyronie\u2019s disease","volume":"106","author":"Raheem","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0790","doi-asserted-by":"crossref","first-page":"E428","DOI":"10.5489\/cuaj.6205","article-title":"Outcome analysis of patients with Peyronie\u2019s disease who elect for vacuum erection device therapy","volume":"14","author":"MacDonald","year":"2019","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2025.04.010_b0795","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urology.2018.07.039","article-title":"The effect of adjunct mechanical traction on penile length in men undergoing primary treatment for Peyronie\u2019s disease: a systematic review and meta-analysis","volume":"122","author":"Haney","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.04.010_b0800","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jsxm.2018.08.012","article-title":"Sildenafil 25 mg ODT + collagenase Clostridium hystoliticum vs collagenase Clostridium hystoliticum alone for the management of Peyronie\u2019s disease: a matched-pair comparison analysis","volume":"15","author":"Cocci","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0805","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1743-6109.2005.20113.x","article-title":"A surgical algorithm for men with combined Peyronie\u2019s disease and erectile dysfunction: functional and satisfaction outcomes","volume":"2","author":"Mulhall","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0810","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jsm.12337","article-title":"Concordance between patient and physician assessment of the magnitude of Peyronie\u2019s disease curvature","volume":"11","author":"Matsushita","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0815","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-5347(17)63751-0","article-title":"Congenital curvature of the phallus: report of three cases with description of corrective operation","volume":"93","author":"Nesbit","year":"1965","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0820","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-5347(17)39871-3","article-title":"Modified corporoplasty for the treatment of penile curvature","volume":"143","author":"Yachia","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.04.010_b0825","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/andr.12431","article-title":"Surgical correction of Peyronie\u2019s disease via tunica albuginea plication: long\u2010term follow\u2010up","volume":"6","author":"Seveso","year":"2018","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.04.010_b0830","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11934-014-0446-x","article-title":"Surgical management of Peyronie\u2019s disease","volume":"15","author":"Zaid","year":"2014","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.eururo.2025.04.010_b0835","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/andr.12421","article-title":"Grafts for Peyronie\u2019s disease: a comprehensive review","volume":"6","author":"Garcia-Gomez","year":"2018","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.04.010_b0840","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/j.1743-6109.2012.02849.x","article-title":"A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie\u2019s disease: measured lengths and patient perceptions","volume":"9","author":"Rybak","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0845","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1743-6109.2005.20234.x","article-title":"Erectile dysfunction following surgical correction of Peyronie\u2019s disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction","volume":"2","author":"Levine","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0850","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bju.12565","article-title":"Outcomes of surgical treatment of Peyronie\u2019s disease","volume":"113","author":"Carson","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0855","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.ijir.3900515","article-title":"A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie\u2019s disease","volume":"12","author":"Levine","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.04.010_b0860","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1743-6109.2007.00407.x","article-title":"Surgical techniques: modeling technique for penile curvature","volume":"4","author":"Wilson","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.04.010_b0865","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1464-410X.2010.10023.x","article-title":"The management of residual curvature after penile prosthesis implantation in men with Peyronie\u2019s disease","volume":"108","author":"Garaffa","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.04.010_b0870","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jsxm.2018.02.024","article-title":"Penile prosthesis implantation in patients with Peyronie\u2019s disease: results of the PROPPER study demonstrates a decrease in patient-reported depression","volume":"15","author":"Khera","year":"2018","journal-title":"J Sex Med"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:23:18Z","timestamp":1749662598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283825002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0302283825002118"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.04.010","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}